There are times when discussions about the economy, personal finance, and business expenses feel just as overwhelming as managing your budget. It is hard to know what you think is happening, when it ...
The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K that’s behind early surges in the United Kingdom, Canada and Japan. Now, with ...
A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...
Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has raised $120 million in an ...
Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors Solve ...
It’s an emerging economic narrative that we’ve been talking about for a while now: Upper-income consumers are going out and spending money, while lower-income consumers are pulling back. In other ...
The governor held a press conference on Monday where he highlighted the success of a public-private partnership aimed at removing Pythons from Florida's Everglades.Gov. Ron DeSantis shared the success ...
It’s human nature to wait until the last minute rather than plan ahead—perhaps especially when it comes to retirement planning. There’s always plenty of other excellent uses for your money, until ...
In the track staff's first year of recruiting they have signed 53 student-athletes MANHATTAN, Kan. – K-State Director of Track and Field/Cross Country Travis Geopfert announced on Wednesday (October ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback